SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000010
Filing Date
2007-02-23
Accepted
2007-02-23 10:03:49
Documents
3
Period of Report
2007-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR SIGMA TAU LETTER EUROPE sigmataulettereurope.htm 8-K 24414
2 SIGMA TAU LETTER sigmatauletter.htm EX-10.1 8693
3 SIGMA TAU LETTER sigmatauletter.pdf EX-10.1 35158
  Complete submission text file 0000812796-07-000010.txt   83449
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 07644122
SIC: 2834 Pharmaceutical Preparations